Xenetic Biosciences, Inc. (XBIO)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 3.9900 |
| Open | 4.2000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 3.9000 - 4.2000 |
| 52-week range | 2.5500 - 5.9700 |
| Volume | |
| Avg. volume | 5,553 |
| Market cap | 6.227M |
| Beta (5Y monthly) | 2.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.7100 |
| Earnings date | 09 Aug 2024 - 13 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksXenetic Biosciences (XBIO) Reports Q1 Loss, Misses Revenue Estimates
Xenetic Biosciences (XBIO) delivered earnings and revenue surprises of 1.27% and 21.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Simply Wall St.Xenetic Biosciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Xenetic Biosciences ( NASDAQ:XBIO ) Full Year 2023 Results Key Financial Results Revenue: US$2.54m (up 49% from FY...
Simply Wall St.Most Shareholders Will Probably Agree With Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation
Key Insights Xenetic Biosciences will host its Annual General Meeting on 6th of December Total pay for CEO Jeff...
© 2024 Yahoo. All rights reserved.